Ellis Investment Partners, LLC Coherus Bio Sciences, Inc. Transaction History

Ellis Investment Partners, LLC

4 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2020 Oct 19, 2020	SELL	$17.41 - $19.89 $5,223 - $5,967	-300 Reduced 30.0%	700 $12,000
Q2 2019 Jul 24, 2019	SELL	$13.1 - $22.1 $460,203 - $776,373	-35,130 Reduced 97.23%	1,000 $22,000
Q1 2019 Apr 24, 2019	BUY	$8.38 - $15.5 $164,616 - $304,482	19,644 Added 119.16%	36,130 $36,000
Q1 2019 Apr 22, 2019	BUY	$8.38 - $15.5 $138,152 - $255,533	16,486 New	16,486 $155,000

132

77.3M

40.7K

50.1K

Ticker CHRS
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 77,724,600
Market Cap $87.1M
Description
Coherus BioSciences, Inc., a biopharmaceutical company, focuses on the biosimilar and immuno-oncology market primarily in the United States. The company markets UDENYCA, a biosimilar to Neulasta, a long-acting granulocyte stimulating colony factor in the United States. Its pipeline products include biosimilars of Humira, Avastin, and Lucentis. T...

Get notified when there are updates to the investment portfolio of Ellis Investment Partners, LLC, based on Form 13F filings with the SEC.

Stay updated on Ellis Investment Partners, LLC with notifications on news.